1 Siegel RL,Miller KD,Fedewa SA,et al.Colorectal cancer statistics,2017[J].CA Cancer J Clin,2017,67(3):104-17. 2 Amagase H.Clarifying the real bioactive constituents of garlic[J].J Nutr,2006,136(3 Suppl):716-725. 3 Amagase H,Petesch BL,Matsuura H,et al.Intake of garlic and its bioactive components[J].J Nutr,2001,131(3):955-962. 4 Hirsch K,Danilenko M,Giat J,et al.Effect of purified allicin,the major ingredient of freshly crushed garlic,on cancer cell proliferation[J].Nutr Cancer,2000,38(2):245-254. 5 Sigounas G,Hooker J,Anagnostou A,et al.S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia,breast,and prostate cancer cell lines[J].Nutr Cancer,1997,27(2):186-191. 6 Xu L,Yu J,Zhai D,et al.Role of JNK activation and mitochondrial Bax translocation in allicin-induced apoptosis in human ovarian cancer SKOV3 cells[J].Evid Based Complement Alternat Med,2014,2014:378684. 7 Lu Y,He Z,Shen X,et al.Cholesterol-lowering effect of allicin on hypercholesterolemic ICR mice[J].Oxid Med Cell Longev,2012,2012(14):489690. 8 Adams JM,Cory S.The Bcl-2 protein family:arbiters of cell survival[J].Science,1998,281(5381):1322-1326. 9 Park SY,Cho SJ,Kwon HC,et al.Caspase-independent cell death by allicin in human epithelial carcinoma cells:involvement of PKA[J].Cancer Lett,2005,224(1):123-132. 10 Sun X,Huang J,Homma T,et al.Genetic alterations in the PI3K pathway in prostate cancer[J].Anticancer Res,2009,29(5):1739-1743. 11 Bitting RL,Armstrong AJ.Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer[J].Endocr Relat Cancer,2013,20(3):83. 12 Huret JL,Dessen P,Bernheim A.Atlas of genetics and cytogenetics in oncology and haematology,updated[J].Nucleic Acids Res,2000,28(1):272-274. 13 Yardley DA.Combining mTOR inhibitors with chemotherapy and other targeted therapies in advanced breast cancer:rationale,clinical experience,and future directions[J].Breast Cancer(Auckl),2013,7(7):7-22. 14 Yuan RR,Kay A,Berg WJ,et al.Targeting tumorigenesis:development and use of mTOR inhibitors in cancer therapy[J].J Hematol Oncol,2009,2(1):45. 15 Villanueva A,Chiang D,Newell P,et al.Pivotal role of mTOR signaling in hepatocellular carcinoma[J].Gastroenterology,2008,135(6):1-11. |